de Swart, Louise <br/><br/>
Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes.  [electronic resource] 

 -  Haematologica  01 2018 
 - 69-79 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2017.171884  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers<br/>Blood Transfusion--methods<br/>Erythropoietin--therapeutic use<br/>Female<br/>Humans<br/>Iron--metabolism<br/>Iron Overload--etiology<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--blood<br/>Prognosis<br/>Proportional Hazards Models